Incubation with exosomes from doxorubicin-resistant breast cancer cells or knockdown of PTEN enhanced the resistance to doxorubicin, which was prevented by the treatment of miR-3613-5p inhibitor (Figures 5(c)–5(e)). The gene discussed is PTEN; the disease is breast cancer.